cirrhosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic liver injury from factors like alcohol, hepatitis, or non-alcoholic fatty liver disease leads to persistent inflammation and hepatocyte death. In response, the liver attempts to repair itself by activating hepatic stellate cells, which transform into myofibroblasts, depositing excessive collagen and extracellular matrix, causing fibrosis and architectural distortion.

• Secondary mechanism: Progressive fibrosis disrupts hepatic blood flow, increasing intrahepatic vascular resistance. This results in portal hypertension, where elevated pressure in the portal venous system leads to the development of varices, splenomegaly, and ascites due to fluid transudation.

• Key complication: Hepatic encephalopathy arises from impaired detoxification of ammonia and other neurotoxins, secondary to reduced functional hepatocyte mass and portosystemic shunting, causing neuropsychiatric disturbances ranging from confusion to coma.

Patient Profile

Demographics:

54-year-old male, retired construction worker

History:

• Key past medical history: Chronic alcohol use disorder, hepatitis C infection, type 2 diabetes, hypertension

• Current medications: Furosemide, spironolactone, lactulose, metformin, lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and distension

• Key symptoms: Jaundice, confusion, hematemesis, peripheral edema, fatigue

• Vital signs: Blood pressure 88/54 mmHg, heart rate 112 bpm, respiratory rate 24 breaths per minute, temperature 38.3°C, oxygen saturation 88% on room air

Section 1

New Complications:

As the healthcare team continues to manage the patient's chronic liver disease, a new complication emerges: spontaneous bacterial peritonitis (SBP). The patient's abdominal pain and distension have intensified, prompting an urgent paracentesis to evaluate the ascitic fluid. The laboratory analysis reveals an elevated white blood cell count with a predominance of neutrophils, confirming the diagnosis of SBP. This bacterial infection of the ascitic fluid adds a significant burden to the patient's already compromised condition.

In response to the diagnosis of SBP, the medical team initiates intravenous broad-spectrum antibiotics, specifically cefotaxime, to target the most common bacterial pathogens. Despite this intervention, the patient's clinical status deteriorates further. His confusion escalates into stupor, indicating a worsening of hepatic encephalopathy. Laboratory tests reveal a critically high ammonia level, and liver function tests show a notable increase in bilirubin and transaminases, reflecting worsening liver function. Additionally, the patient's blood pressure remains low despite fluid resuscitation, and his oxygen saturation continues to decline, now at 85% on room air, suggesting the potential development of hepatorenal syndrome.

This development necessitates a multidisciplinary approach, involving hepatology, infectious disease, and critical care teams. The priority is to stabilize the patient's hemodynamics, manage the infection aggressively, and address the worsening encephalopathy. The team must also consider the possibility of liver transplantation evaluation, given the severity of the liver dysfunction and the rapid progression of complications. This challenging situation requires advanced clinical judgment to balance the risks and benefits of aggressive interventions while preparing for potential long-term solutions.

Section 2

The patient's condition continues to decline, prompting a reevaluation of his current status. On reassessment, vital signs indicate a persistent hypotension with blood pressure readings of 85/50 mmHg, despite continuous fluid resuscitation. Heart rate is elevated at 125 beats per minute, and respiratory rate has increased to 30 breaths per minute, reflecting respiratory distress. His oxygen saturation has further decreased to 78% on room air, necessitating the initiation of supplemental oxygen via a non-rebreather mask, which only marginally improves saturation levels to 85%. Neurologically, the patient remains stuporous, with a Glasgow Coma Scale score of 8, indicating a significant decline in mental status.

Laboratory results reveal a serum creatinine level of 3.5 mg/dL, up from 1.2 mg/dL earlier, consistent with acute kidney injury and suggesting the development of hepatorenal syndrome. The liver function tests show a further increase in total bilirubin to 15 mg/dL and AST/ALT levels soaring to 350/400 IU/L, respectively, highlighting ongoing hepatic deterioration. Coagulation studies reveal an INR of 2.2, indicating compromised synthetic liver function. Arterial blood gas analysis shows a pH of 7.28, pCO2 of 50 mmHg, and HCO3- of 19 mmol/L, pointing towards a mixed respiratory and metabolic acidosis, complicating the clinical picture further.

In light of these findings, the multidisciplinary team decides to escalate care by transferring the patient to the intensive care unit for closer monitoring and advanced support. The focus shifts towards aggressive management of the hepatorenal syndrome with the consideration of terlipressin and albumin therapy to improve renal perfusion. Concurrently, non-invasive ventilation is contemplated to address the respiratory failure. Given the rapid decline, discussions regarding the patient's candidacy for liver transplantation are expedited, considering the limited window of opportunity for intervention. The team faces the formidable task of balancing immediate life-saving measures with the pursuit of long-term, definitive solutions.

Section 3

Following the patient's transfer to the intensive care unit, the team initiates aggressive interventions targeting the acute complications. Terlipressin and albumin therapy are commenced to address the hepatorenal syndrome, with close monitoring of renal function and hemodynamic stability. Despite these efforts, the patient's condition remains precarious. Within hours, his blood pressure falls further to 80/45 mmHg, necessitating the initiation of vasopressor support with norepinephrine to maintain adequate perfusion. Despite the non-rebreather mask, his oxygen saturation struggles to rise above 86%, prompting the decision to transition to bilevel positive airway pressure (BiPAP) to support his failing respiratory effort.

In response to these interventions, there is a modest improvement in the patient's respiratory parameters; his respiratory rate decreases to 26 breaths per minute, and arterial blood gas analysis shows a slight correction in pH to 7.32, though hypercapnia and acidosis persist, with pCO2 at 48 mmHg and HCO3- remaining at 20 mmol/L. Despite the stabilization of some parameters, the patient's neurological status continues to decline, with a Glasgow Coma Scale score dropping further to 6, necessitating intubation and mechanical ventilation to secure the airway and optimize oxygenation.

Amidst these developments, new complications arise. The patient's abdomen becomes increasingly distended, and an ultrasound reveals tense ascites with signs of spontaneous bacterial peritonitis (SBP). Paracentesis is performed, and analysis of the ascitic fluid shows an elevated white cell count, consistent with infection. Empirical antibiotic therapy with intravenous cefotaxime is initiated promptly. The progression of SBP further complicates the clinical picture, placing additional strain on his already compromised liver function and necessitating a reevaluation of his candidacy for urgent liver transplantation. As the team navigates these complex challenges, the focus remains on stabilizing the patient while assessing all potential pathways to optimize his chances for recovery and long-term survival.

Section 4

As the intensive care team continues to manage the cascade of complications, they are confronted with a new set of diagnostic results that further complicate the patient's clinical picture. Laboratory findings reveal a marked coagulopathy with an International Normalized Ratio (INR) elevated to 3.5, indicative of significant hepatic synthetic dysfunction. Additionally, the patient's complete blood count shows a declining platelet count, now at 48,000/mm³, raising concerns for potential bleeding risks and disseminated intravascular coagulation (DIC). Liver function tests show worsening transaminases, with AST and ALT both exceeding 300 U/L, and bilirubin levels climbing to 7.8 mg/dL, reflecting an exacerbation of hepatic failure.

Amidst these alarming laboratory values, the patient's hemodynamic stability remains tenuous, with norepinephrine requirements escalating to maintain mean arterial pressure above 65 mmHg. Despite aggressive fluid resuscitation and vasopressor support, the patient's renal function continues to deteriorate, with serum creatinine rising to 3.2 mg/dL and urine output dwindling to less than 20 mL/hour, signaling a progression of hepatorenal syndrome. The critical care team, in collaboration with nephrology, debates the timing of renal replacement therapy, weighing the risks of further hemodynamic compromise against the potential benefits of dialysis in managing fluid overload and metabolic derangements.

In light of the evolving clinical scenario, the multidisciplinary team intensifies their discussions on the feasibility of liver transplantation as a definitive intervention. A comprehensive assessment of the patient's Model for End-Stage Liver Disease (MELD) score, now calculated at 40, underscores the urgency of transplantation consideration. However, the presence of active infection, ongoing organ failures, and the need for escalating life support measures prompt a thorough evaluation of transplant candidacy criteria. The team remains focused on balancing the immediate stabilization efforts with the need for expedited transplant listing, recognizing the precarious balance between survival and the progression of multi-organ dysfunction.

Section 5

As the multidisciplinary team works diligently to manage the patient's complex and rapidly evolving condition, a significant change in the patient's status emerges. Over a period of several hours, the patient develops increased respiratory distress, characterized by a sudden rise in respiratory rate to 32 breaths per minute and a decline in oxygen saturation to 88% on a high-flow nasal cannula delivering 60% FiO2. Auscultation of the lungs reveals bilateral crackles, suggesting pulmonary edema. A stat chest X-ray confirms diffuse bilateral infiltrates, consistent with acute respiratory distress syndrome (ARDS), likely secondary to fluid overload and systemic inflammatory response.

In response to the new pulmonary complication, the critical care team initiates ventilatory support, transitioning the patient to non-invasive positive pressure ventilation. Despite this intervention, the patient's respiratory status continues to deteriorate, necessitating endotracheal intubation and mechanical ventilation. The ventilator settings are carefully adjusted to optimize oxygenation while minimizing barotrauma, with a focus on low tidal volume ventilation and adequate positive end-expiratory pressure (PEEP) to improve alveolar recruitment.

The escalation of the patient's clinical status prompts the team to re-evaluate the overall treatment strategy. The critical care team convenes urgently with pulmonology and transplant surgery to reassess the patient's candidacy for liver transplantation. The discussion emphasizes the need for aggressive management of ARDS and close monitoring of the patient's response to ventilatory support. Simultaneously, nephrology reconsiders the initiation of continuous renal replacement therapy (CRRT) to address worsening renal function and fluid overload, ensuring that all possible measures are taken to stabilize the patient and keep the possibility of transplantation viable. The team remains acutely aware of the delicate balance required to optimize organ function and improve the patient's chances for a successful transplant outcome.